Bupropion	bupropion	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
Zyban	zyban	O	O	OTHERS	I
)	)	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Bupropion	bupropion	CHEMICALS	O	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
monocyclic	monocyclic	O	O	O	O
antidepressant	antidepressant	CHEMICALS	O	OTHERS	I
structurally	structurally	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
amphetamine	amphetamine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Zyban	zyban	O	O	OTHERS	I
,	,	O	O	O	O
a	a	O	O	O	O
sustained-release	sustained-release	O	O	O	O
formulation	formulation	O	O	O	O
of	of	O	O	O	O
bupropion	bupropion	CHEMICALS	O	OTHERS	I
hydrochloride	hydrochloride	O	O	OTHERS	I
,	,	O	O	O	O
was	was	O	O	O	O
recently	recently	O	O	O	O
released	released	O	O	O	O
in	in	O	O	O	O
Ireland	ireland	O	O	O	O
,	,	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
smoking	smoking	CHEMICALS	O	OTHERS	I
cessation	cessation	O	O	O	O
aid	aid	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
initial	initial	O	O	O	O
6	6	O	O	O	O
months	months	O	O	O	O
since	since	O	O	O	O
it	it	O	O	O	O
's	's	O	O	O	O
introduction	introduction	O	O	O	O
,	,	O	O	O	O
12	12	O	O	O	O
overdose	overdose	O	DISEASE	OTHERS	I
cases	cases	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
to	to	O	O	O	O
The	the	O	O	O	O
National	national	O	O	O	O
Poisons	poisons	O	O	O	O
Information	information	O	O	O	O
Centre	centre	O	O	O	O
.	.	O	O	O	O

8	8	O	O	O	O
patients	patients	O	O	O	O
developed	developed	O	O	O	O
symptoms	symptoms	O	O	O	O
of	of	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Common	common	O	O	O	O
features	features	O	O	O	O
included	included	O	O	O	O
tachycardia	tachycardia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
drowsiness	drowsiness	O	O	OTHERS	I
,	,	O	O	O	O
hallucinations	hallucinations	O	DISEASE	OTHERS	I
and	and	O	O	O	O
convulsions	convulsions	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Two	two	O	O	O	O
patients	patients	O	O	O	O
developed	developed	O	O	O	O
severe	severe	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
arrhythmias	arrhythmias	O	DISEASE	OTHERS	I
,	,	O	O	O	O
including	including	O	O	O	O
one	one	O	O	O	O
patient	patient	O	O	O	O
who	who	O	O	O	O
was	was	O	O	O	O
resuscitated	resuscitated	O	O	O	O
following	following	O	O	O	O
a	a	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
arrest	arrest	O	DISEASE	OTHERS	I
.	.	O	O	O	O

All	all	O	O	O	O
patients	patients	O	O	O	O
recovered	recovered	O	O	O	O
without	without	O	O	O	O
sequelae	sequelae	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
31	31	O	O	O	O
year	year	O	O	O	O
old	old	O	O	O	O
female	female	O	O	O	O
who	who	O	O	O	O
required	required	O	O	O	O
admission	admission	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
Intensive	intensive	O	O	O	O
Care	care	O	O	O	O
Unit	unit	O	O	O	O
for	for	O	O	O	O
ventilation	ventilation	O	O	O	O
and	and	O	O	O	O
full	full	O	O	O	O
supportive	supportive	O	O	O	O
therapy	therapy	O	O	O	O
,	,	O	O	O	O
following	following	O	O	O	O
ingestion	ingestion	O	O	O	O
of	of	O	O	O	O
13.5	13.5	O	O	O	O
g	g	O	O	O	O
bupropion	bupropion	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Recurrent	recurrent	O	O	O	O
seizures	seizures	O	DISEASE	OTHERS	I
were	were	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
diazepam	diazepam	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
broad	broad	O	O	O	O
complex	complex	O	O	O	O
tachycardia	tachycardia	O	DISEASE	OTHERS	I
was	was	O	O	O	O
successfully	successfully	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
adenosine	adenosine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Zyban	zyban	O	O	OTHERS	I
caused	caused	O	O	O	O
significant	significant	O	O	O	O
neurological	neurological	O	O	O	O
and	and	O	O	O	O
cardiovascular	cardiovascular	O	O	OTHERS	I
toxicity	toxicity	O	DISEASE	OTHERS	I
in	in	O	O	O	O
overdose	overdose	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
potential	potential	O	O	O	O
toxic	toxic	O	O	O	O
effects	effects	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
considered	considered	O	O	O	O
when	when	O	O	O	O
prescribing	prescribing	O	O	O	O
it	it	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
smoking	smoking	CHEMICALS	O	OTHERS	I
cessation	cessation	O	O	O	O
aid	aid	O	O	O	O
.	.	O	O	O	O

